Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this RCT is to determine the efficacy of a single preoperative dose of Dexamethasone for accelerating the recovery and reducing the incidence of postoperative complications in adult patients undergoing intestinal resection for inflammatory bowel disease.
Patients undergoing surgery for IBD is associated with increased inflammatory response and incidence of prolonged ileus after surgery compared to other colorectal disease such as CRC. Previous studies have revealed that preoperative administration of glucocorticosteroids(GCs) decreased complications and length of postoperative length of hospital after major abdominal surgery as a likely consequence of attenuating the postsurgical inflammatory response. Also, a single dose of GCs did not increase complications in colorectal surgery. The aim of the study is to examine whether a single dose of dexamethasone prior to induction of anesthesia could promote the recovery of patients and reduce the incidence of prolonged ileus after surgery for IBD
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dexamethasone | Experimental | Dexamethasone 8mg intravenously prior to anesthesia induction |
|
| Control | Placebo Comparator | Normal Saline 1.6ml intravenously prior to anesthesia induction |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexamethasone | Drug | Dexamethasone 8mg intravenously prior to induction of anesthesia |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Prolonged ileus | Prolonged POI was defined as if two or more of the following five criteria are met on day 4 postoperatively: nausea or vomiting; inability to tolerate an oral diet over last 24 h; absence of flatus over last 24 h; abdominal distension; and radiologic confirmation. | Day 30 |
| Measure | Description | Time Frame |
|---|---|---|
| PONV(Postoperative nausea and vomiting) and additional antiemetics given within 24hr after surgery | the incidence of any nausea, emetic episodes (retching or vomiting),or both (i.e., postoperative nausea and vomiting) during the first 24 postoperative hours. | 24hr |
| Postoperative pain on POD 1, 3, and 5 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jianfeng Gong, MD | Jinling Hospital, China | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University | Nanjing | Jiangsu | 210000 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33749741 | Derived | Zhang T, Xu Y, Yao Y, Jin L, Liu H, Zhou Y, Gu L, Ji Q, Zhu W, Gong J. Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 Oct 20;27(11):1756-1765. doi: 10.1093/ibd/izab065. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D011183 | Postoperative Complications |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D003907 | Dexamethasone |
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Normal saline |
| Drug |
Normal saline 1.6ml intravenously prior to induction of anesthesia |
|
Visual analog scale (VAS) for pain description (0-10 visual analogue pain scale) |
| up to 1 week |
| Postoperative fagitue score on POD 1, 3, and 5 | Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale (Version 4). The FACIT-IT score is a 13-item tool that measures an individual's level of fatigue during their usual daily activities over the past week. The level of fatigue is measured on a four point Likert scale (4 = not at all fatigued to 0 = very much fatigued) | up to 1 week |
| GI-2 recovery | time to upper (first tolerance of solid food) and lower (first bowel movement) GI recovery (GI-2). | Day 30 |
| Blood WBC levels, preoperative and on postoperative 1,3 and 5 | Blood WBC levels, preoperative and on postoperative 1,3 and 5 | Day 30 |
| Blood neutrophil percentage, preoperative and on postoperative 1,3 and 5 | Blood neutrophil percentage, preoperative and on postoperative 1,3 and 5 | Day 30 |
| Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and 5 | Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and | Day 30 |
| Serum Interleukin-6 (IL-6) level, preopperative and on postoperative 1,3 and 5 | Serum Interleukin-6 (IL-6) level, preopperative and on postoperative 1,3 and 5 | Day 30 |
| Serum procalcitonin (PCT) level, preopperative and on postoperative 1,3 and 5 | Serum procalcitonin (PCT) level, preopperative and on postoperative 1,3 and 5 | Day 30 |
| Body composition, preoperative and on POD 1 | body composition was determined using Bioelectrical impedance analysis (BIA) | Day 30 |
| Postoperative length of stay | in days | Day 90 |
| Postoperative morbidity | Documented using comprehensive complication index(CCI) | Day 30 |
| Postoperative surgical site infections (SSIs) | Including superficial SSIs and deep SSIs. | Day 30 |
| Overall cost of treatment | In Chinese Yuan (CNY) | up to 1 year |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D000072473 |
| Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |